A Method to Diagnose the Risk for and Prevent Breast Inflammation and Breast Cancer
UC San Diego researchers have invented new methods to detect entry of inflammatory mediators in normal (or diseased) breasts as well as ways to prevent the inflammation. Although the disclosed techniques focus on breast cancer, this diagnostic technology may be applicable to other similar diseased conditions, including prostate inflammation and cancer, ovarian and colon inflammation and cancer, and certain forms of brain inflammation and cancer. More generally, this technology is applicable to inflammation and cancers derived from epithelial cells, namely carcinomas.
Patent Number: US20130158394A1
Application Number: US13522324A
Inventor: Hon, Sylvia | Khosraviani, Anahitta | Miglani, Amar | Smith, David Brandon | Sung, Lanping Amy | Schmid-Schonbein, Geert W.
Priority Date: 14 Jan 2010
Priority Number: US20130158394A1
Application Date: 7 Mar 2013
Publication Date: 20 Jun 2013
IPC Current: A61B000500 | A61F000537 | A61M003100
US Class: 600431 | 128887 | 604503 | 606213 | 606228
Assignee Applicant: The Regents of the University of California
Title: Devices, Systems and Methods to Detect and Reduce or Prevent Entry of Inflammatory Mediators into Milk Ducts
Usefulness: Devices, Systems and Methods to Detect and Reduce or Prevent Entry of Inflammatory Mediators into Milk Ducts
Summary: Detecting method of assessing and promoting breast health through open lactiferous duct.
Novelty: Detecting method of assessing and promoting breast health through open lactiferous duct involves detecting presence of contrast medium in lactiferous duct in order to determine if lactiferous duct is open
Biomedical
Medical Device
Additional Technologies by these Inventors Tech ID/UC Case 19428/2009-163-0 Related Cases 2009-163-0, 2010-179-1
USA
